Arcellx (ACLX) Net Margin (2023 - 2025)

Arcellx (ACLX) recorded quarterly Net Margin of 3513.42% in Q4 2025, down 208.63% quarter-over-quarter from 1138.39% in Q3 2025, and down 320502.0% on a YoY basis from N/an in Q4 2024.

Arcellx (ACLX) Net Margin (2023 - 2025) Analysis & Trends

Arcellx's Net Margin history runs 3 years deep, the most recent figure standing at 3513.42% for Q4 2025.

  • In Q4 2025, Net Margin fell 320502.0% year-over-year to 3513.42%; the TTM figure through Dec 2025 stood at 1027.39% (down 92800.0% YoY), while the FY2025 annual figure was 1027.25%, down 92780.0% from the prior year.
  • Net Margin was 3513.42% for Q4 2025 at Arcellx, down from 1138.39% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 31.42% in Q4 2023 to a low of 3513.42% in Q4 2025.
  • Historically, Net Margin has averaged 599.03% across 3 years, with a median of 214.89% in 2023.
  • The sharpest annual moves came in 2024 and 2025: Net Margin jumped 16371 bps in 2024, then sank 320502 bps in 2025.
  • A 3-year view of Net Margin shows it stood at 31.42% in 2023, then tumbled by 1081 bps to 308.4% in 2024, then plunged by 1039 bps to 3513.42% in 2025.
  • The last three Net Margin figures came in at 3513.42% (Q4 2025), 1138.39% (Q3 2025), and 694.36% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arcellx 6.48 Bn 6.48 Bn - -3,513.42%

Historic Data

Download Data
DateValue
Dec 31, 2025 -3,513.42%
Sep 30, 2025 -1,138.39%
Jun 30, 2025 -694.36%
Mar 31, 2025 -766.02%
Dec 31, 2024 -308.40%
Sep 30, 2024 -99.29%
Jun 30, 2024 -99.19%
Mar 31, 2024 -18.34%
Dec 31, 2023 31.42%
Sep 30, 2023 -262.99%
Jun 30, 2023 -166.79%
Mar 31, 2023 -152.66%